Aarti Drugs Limited has informed the Exchange about Schedule of meet
AARTIDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Drugs Limited has scheduled a quarterly earnings conference call for investors and analysts on July 21, 2025 at 11:00 AM IST to discuss the company's financial performance for Q1 FY26 (quarter ended June 30, 2025). The call will be attended by senior leadership including the Joint Managing Director (Mr. Harshit Savla), Whole Time Director (Mr. Harit Shah), and CFO & COO (Mr. Adhish Patil). The Managing Director of subsidiary Pinnacle Life Science Private Limited (Mr. Vishwa Savla) will also participate. The call is being organized by Strategic Growth Advisors Pvt. Ltd. and is accessible via dial-in numbers across India, the US, the UK, Singapore, and Hong Kong.
This is a routine regulatory disclosure with no direct impact on the stock price. However, it signals that Q1 FY26 results are imminent and gives investors an early opportunity to hear management's commentary, outlook, and any strategic updates before formal results are filed.